Resilient Biopharma Leadership With Ambrx's Dan O'Connor
Business Of Biotech
00:00
The Challenges of the Capital Markets Environment
I want to learn, you know, about that experience with the ATM and sort of get your perspective on the characterization of the capital markets environment right now. I'm going to let you pick a, let's do a little choose your own adventure, Dan. You want to tell us about your metastatic breast cancer in prostate candidates? I'mGoing to talk about the market. Yeah. The small cap biotech companies are extremely important part of the ecosystem because they're really putting forward the treatments that big farmers not going to work on or try to tackle.
Transcript
Play full episode
